Acute myeloblastic leukemia as a second malignancy in a patient with hereditary retinoblastoma.
Nishimura
S
S
Sato
T
T
Ueda
H
H
Ueda
K
K
D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016190:Carboplatin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007223:Infant; D015470:Leukemia, Myeloid, Acute / Q000139:chemically induced*; D016609:Neoplasms, Second Primary / Q000139:chemically induced*; D019572:Retinal Neoplasms / Q000188:drug therapy* / Q000235:genetics; D012175:Retinoblastoma / Q000188:drug therapy* / Q000235:genetics
D000972:Antineoplastic Agents, Phytogenic; D005047:Etoposide; D016190:Carboplatin